Oct 18, 2018 Last Updated 12:11 PM, Oct 16, 2018

In the eye of the (cytokine) storm.

Published in Head news
Read 222 times
Rate this item
(0 votes)

Cytokine release syndrome (CRS) is a pathological condition, triggered by a massive production of pro-inflammatory cytokines -often referred to as "cytokine storm"- associated to many infectious and non-infectious conditions. Its clinical features include fever, vascular leakage, hypotension and, in some individuals even neurotoxicity and death.

 

CRS can also be associated to chimeric antigen receptor (CAR)-expressing T cell-based therapies, often used in patients with blood malignancies and, as a matter of fact, it represents one of the major obstacles to broader uses of this terapeutic approach. This month, Lucy Bird, of Nature Reviews Immunology, highlighted two papers that investigated the molecular mechanisms of CRS in mouse models. Avoiding the cytokine storm and its deleterious effects might be an important achievement in order to extend the therapeutic use of CAR-expressing T cell transfer to other pathologies.

Source:Nature Reviews Immunology

Original paper (only for registered users). 

Last modified on Wednesday, 13 June 2018 13:52
Login to post comments

Registered area

Thanks to the support of
merck serono biogen sanofi

Conferences & Courses

17° Corso CRNI Viva la differenza: sesso e neuroimmunologia

March 7-10, 2018 
Bergamo - Bergamo Science Center

READ MORE

Encefaliti Autoimmuni e Malattie Demielinizzanti Atipiche

16 febbraio 2018
Aula Magna Giorgio De Sandre
POLICLINICO UNIVERSITARIO G.B. ROSSI - Verona

READ MORE

JNIInternational Brain Research Organization
Bringing Neuroscience to the World
JNIJournal of Neuroimmunology
Studies on all branches of neurosciences covering both research and clinical problems of neuroscientific interest.

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies. To find out more about the cookies we use and how to delete them, see our Cookie Policy